Viewing Study NCT04395092


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-02-02 @ 3:42 AM
Study NCT ID: NCT04395092
Status: WITHDRAWN
Last Update Posted: 2021-06-22
First Post: 2020-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
Sponsor: Kiadis Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia (AML) View
None Myelodysplastic Syndromes (MDS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None K-NK002 View
None NK cell therapy View
None AML View
None MDS View